Phase I/II Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix
Phase of Trial: Phase I/II
Latest Information Update: 06 Dec 2019
Price : $35 *
At a glance
- Drugs Niraparib (Primary) ; Carboplatin; Paclitaxel
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms NIVIX
- 17 Jul 2019 Status changed from not yet recruiting to recruiting.
- 09 Jul 2019 Planned initiation date changed from 21 Apr 2019 to 31 Jul 2019.
- 10 Jan 2019 Planned initiation date changed from 17 Sep 2018 to 21 Apr 2019.